Galva Technologies Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Galva Technologies Tbk. trades at Rp326 (market cap 492B, 3.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Galva Technologies Tbk. is far larger — about 3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 3.8K). Which is the better fit depends on your goals.
| GLVA | OBAT | |
|---|---|---|
Market Cap | 492B | 166.01B |
Volume | 3.8K | 324K |
Lot | 38 | 3.24K |
Turnover | 1.23M | 77.68M |
Average Price | 322.53 | 239.75 |
Value | 1.23M | 77.68M |
Indicative Equilibrium Price | 328 | 240 |
Indicative Equilibrium Volume | 200 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Galva Technologies Tbk (the “Company”) was established under the Deed No. 1 dated September 1, 1991 by notary Fransiscus Jacobus Mawati, S.H., notary in Jakarta.
Read more on GLVA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →